- Home
- VALN vs BTO Comparison
VALN vs BTO Comparison
Compare VALN & BTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- BTO
- Stock Information
- Founded
- VALN 2012
- BTO 1994
- Country
- VALN France
- BTO United States
- Employees
- VALN N/A
- BTO N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- BTO Investment Managers
- Sector
- VALN Health Care
- BTO Finance
- Exchange
- VALN Nasdaq
- BTO Nasdaq
- Market Cap
- VALN 777.9M
- BTO 747.9M
- IPO Year
- VALN 2021
- BTO N/A
- Fundamental
- Price
- VALN $8.94
- BTO $36.84
- Analyst Decision
- VALN Strong Buy
- BTO
- Analyst Count
- VALN 4
- BTO 0
- Target Price
- VALN $15.75
- BTO N/A
- AVG Volume (30 Days)
- VALN 129.1K
- BTO 54.2K
- Earning Date
- VALN 11-06-2025
- BTO 01-01-0001
- Dividend Yield
- VALN N/A
- BTO 9.13%
- EPS Growth
- VALN N/A
- BTO N/A
- EPS
- VALN N/A
- BTO N/A
- Revenue
- VALN $230,566,060.00
- BTO N/A
- Revenue This Year
- VALN $15.55
- BTO N/A
- Revenue Next Year
- VALN $23.93
- BTO N/A
- P/E Ratio
- VALN N/A
- BTO N/A
- Revenue Growth
- VALN 25.47
- BTO N/A
- 52 Week Low
- VALN $3.62
- BTO $22.95
- 52 Week High
- VALN $12.25
- BTO $32.81
- Technical
- Relative Strength Index (RSI)
- VALN 49.28
- BTO 50.98
- Support Level
- VALN $8.33
- BTO $37.41
- Resistance Level
- VALN $9.46
- BTO $37.96
- Average True Range (ATR)
- VALN 0.35
- BTO 0.48
- MACD
- VALN -0.15
- BTO -0.04
- Stochastic Oscillator
- VALN 61.30
- BTO 21.62
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About BTO John Hancock Financial Opportunities Fund
John Hancock Financial Opportunities Fund is the United States based closed-end, diversified management investment company. Its investment objective is to provide a high level of total return consisting of long-term capital appreciation and current income. The company invests in banks, capital markets, Insurance, Mortage Real Estate Investment trust, Health Care REITs, Diversified REITs, Office REITs.